Medicine
Ciprofloxacin 200 mg/100 mL injection
Ciprofloxacin 200 mg/100 mL injection is a generic prescription medicine for intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from freezing. Store between 5° and 25°C (41° and 77°F). Protect from…
Key facts
- Active ingredient (INN)
- Ciprofloxacin
- Brand
- Sold under the generic name
- Strength
- 200 mg/100 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 24 pouches of 100 mL
- Manufacturers
- Sagent PharmaceuticalsHospira
- Origin register
- US FDA, United States
- Storage
- Protect from freezing. Store between 5° and 25°C (41° and 77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01MA02 Ciprofloxacin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 24 March 2008
- Identifiers
- RxCUI 1665210, 1665212DailyMed set ID 7049f870-6741-4a67-8033-398c36126a06, f406e796-17d9-4465-b8a7-00d966a4ba74, cbbbf939-3219-4515-a48e-ca264daa4d07NDC 25021-114, 25021-192, 0409-2300Application ANDA078252
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 24 pouch in 1 carton / 1 bag in 1 pouch / 100 mL in 1 bag | 25021-114-82 | Sagent Pharmaceuticals | 24 March 2008 |
| 24 pouch in 1 carton / 1 bag in 1 pouch / 100 mL in 1 bag | 25021-192-82 | Sagent Pharmaceuticals | 15 December 2022 |
| 24 pouch in 1 carton / 1 bag in 1 pouch / 100 mL in 1 bag | 0409-2300-24 | Hospira | 30 June 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 22 October 1987 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Ciprofloxacin
Clinical summary
Ciprofloxacin is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated, among other approved uses. MedsAcross supplies Ciprofloxacin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CiprofloxacinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cipro prescribing information (Bayer HealthCare Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Ciprofloxacin 200 mg/100 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.